Your browser doesn't support javascript.
loading
Intention to prescribe self-injectable epinephrine: are there differences depending on who assesses the patient post-reaction?
Gómez Galán, C; Ferré Ybarz, L; Peña Peloche, MA; Sansosti Viltes, A; Borbolla Morán, JM de la; Torredemer Palau, A; Nevot Falcó, S.
Afiliação
  • Gómez Galán, C; Sant Joan de Déu Hospital. Barcelona. Spain
  • Ferré Ybarz, L; Sant Joan de Déu Hospital. Barcelona. Spain
  • Peña Peloche, MA; Sant Joan de Déu Hospital. Barcelona. Spain
  • Sansosti Viltes, A; Sant Joan de Déu Hospital. Barcelona. Spain
  • Borbolla Morán, JM de la; Sant Joan de Déu Hospital. Barcelona. Spain
  • Torredemer Palau, A; Sant Joan de Déu Hospital. Barcelona. Spain
  • Nevot Falcó, S; Sant Joan de Déu Hospital. Barcelona. Spain
Allergol. immunopatol ; 43(3): 286-291, mayo-jun. 2015. tab, ilus
Artigo em Inglês | IBECS | ID: ibc-136336
Biblioteca responsável: ES1.1
Localização: BNCS
ABSTRACT

INTRODUCTION:

Anaphylaxis is the most severe of all allergic reactions and can even prove fatal. There is limited evidence of a difference in prescribing patterns for self-injectable epinephrine (SIE) between general paediatricians and paediatricians with greater knowledge of allergology.

OBJECTIVES:

Assess knowledge about prescribing SIE of a sample of primary care/hospital paediatricians and paediatricians with specialised knowledge of allergology through a questionnaire asking them about clinical cases of anaphylaxis in their daily paediatric practice. MATERIALS AND

METHODS:

Participants were primary care and hospital paediatricians practicing in different regions of the province of Barcelona and paediatricians with specialised knowledge in the field of allergology from Spain.

RESULTS:

A total of 183 paediatricians responded. Of that 59.6% were paediatricians with specialised knowledge of allergology. General paediatricians in most cases correctly prescribed SIE device (more than 70% answered correctly in five of the eight clinical cases). In the case of drug anaphylaxis, which is an avoidable allergen for which SIE is not indicated, 67.5% of general paediatricians would prescribe it. In the case of exercise-induced anaphylaxis there were also differences in the prescription of epinephrine by general paediatricians, with only 40% prescribing it.

CONCLUSIONS:

In this study the percentage of SIE prescriptions would be higher than expected by general paediatricians, with no differences in the cases proposed between them and the paediatricians with better knowledge of allergology. Despite these results, it is important to insist on conducting education programmes and disseminating them to facilitate physicians' recognition and treatment of anaphylactic reactions
RESUMEN
No disponible
Assuntos
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Epinefrina / Uso de Medicamentos Tipo de estudo: Estudo de avaliação Limite: Feminino / Humanos / Masculino Idioma: Inglês Revista: Allergol. immunopatol Ano de publicação: 2015 Tipo de documento: Artigo Instituição/País de afiliação: Sant Joan de Déu Hospital/Spain
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Epinefrina / Uso de Medicamentos Tipo de estudo: Estudo de avaliação Limite: Feminino / Humanos / Masculino Idioma: Inglês Revista: Allergol. immunopatol Ano de publicação: 2015 Tipo de documento: Artigo Instituição/País de afiliação: Sant Joan de Déu Hospital/Spain
...